meirluc, I wish I knew for sure when the MHRA is going to make its approval decision, but I do believe it will be soon.
NWBio has always consistently said that they will start meeting patient demand by manufacturing DCVax-L in the Class B suite at the Sawston facility after initial approval.
Thankfully, the new simplified C suite will be ready in Q2 2026, and then NWBio can start using Flaskworks devices to significantly increase and scale manufacturing capacity.
Hopefully, this will make all of our friends and family members happy. 😀
Market Data 
Markets 
AI
